Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chlamydia Trachomatis: later-stage trial registry
A small indexed set (5 trials) with no open enrollment listed right now.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count
Chlamydia Trachomatis: 5 US clinical trials tracked, none currently recruiting.
Chlamydia Trachomatis is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of Pittsburgh, running 2 of these trials.
Enrollment posture brief
Registry condition chlamydia-trachomatis
OPEN 0 | RECR 0% | LATE 2 | EARLY 0 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Chlamydia Trachomatis has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chlamydia Trachomatis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chlamydia Trachomatis is recruiting below its size-band peers.
0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Chlamydia Trachomatis research.
University of Pittsburgh accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Chlamydia Trachomatis enrolment sits around 403 participants.
Median target enrolment is 403 among the 5 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.
-
Chlamydia Trachomatis splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Evaluation of the Atlas Genetics io® CTNG System
Binx Health Limited
NCT03071510
Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger
University of California, San Francisco
NCT00618449
Home Screening for Chlamydia Surveillance
University of Pittsburgh
NCT00177437
Multimedia WORTH With Black Drug-Involved Women on Probation
Columbia University
NCT02391233
Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing
University of Pittsburgh
NCT00978848
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Chlamydia Trachomatis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chlamydia Trachomatis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chlamydia Trachomatis page
5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Chlamydia Trachomatis trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- University of Pittsburgh sponsors the most Chlamydia Trachomatis trials on record, review their full trial history before evaluating a specific study. See University of Pittsburgh's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chlamydia Trachomatis condition card totals 5 registered trials; most-linked intervention Streamlined HIV Testing; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.